Paula Perez‐Corredor

<i>APOE3</i> Christchurch Heterozygosity and Autosomal Dominant Alzheimer’s Disease

Yakeel T. Quiroz, David Aguillón, Daniel Camilo Aguirre–Acevedo et al. · New England Journal of Medicine · 2024 · 47 citations · Full text

APOE Christchurch‐mimetic therapeutic antibody reduces APOE‐mediated toxicity and tau phosphorylation

Claudia Mariño, Paula Perez‐Corredor, Michael O’Hare et al. · Alzheimer s & Dementia · 2023 · 37 citations · Full text

APOE3 Christchurch modulates β-catenin/Wnt signaling in iPS cell-derived cerebral organoids from Alzheimer’s cases

Paula Perez‐Corredor, Timothy E. Vanderleest, Guido N. Vacano et al. · Frontiers in Molecular Neuroscience · 2024 · 22 citations · Full text

Microglial APOE3 Christchurch protects neurons from Tau pathology in a human iPSC-based model of Alzheimer’s disease

Guoqiang Sun, Cheng Wang, Randall C. Mazzarino et al. · Cell Reports · 2024 · 16 citations · Full text

An mRNA-encoded dominant-negative inhibitor of transcription factor RUNX1 suppresses vitreoretinal disease in experimental models

Michael O’Hare, William P. Miller, Said Arévalo-Alquichire et al. · Science Translational Medicine · 2024 · 10 citations